Evidence map›Paper›PMID 37508256›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Occurrence of ESBL- and AmpC-Producing

Marisa Haenni, Laetitia Du Fraysseix, Pauline François, Antoine Drapeau, Tristan Bralet, Jean-Yves Madec, Thierry Boulinier, Olivier Duriez

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Marisa HaenniUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de Lyon, 69007 Lyon, France.ORCID 0000-0003-1333-5603
Laetitia Du FraysseixUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de Lyon, 69007 Lyon, France.
Pauline FrançoisUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de Lyon, 69007 Lyon, France.
Antoine DrapeauUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de Lyon, 69007 Lyon, France.
Tristan BraletCEFE, Montpellier University, CNRS, EPHE, IRD, 34090 Montpellier, France.
Jean-Yves MadecUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de Lyon, 69007 Lyon, France.
Thierry BoulinierCEFE, Montpellier University, CNRS, EPHE, IRD, 34090 Montpellier, France.
Olivier DuriezCEFE, Montpellier University, CNRS, EPHE, IRD, 34090 Montpellier, France.
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FR

Funding

French Agency for Food, Environmental and Occupational Health & Safety no grant numberOSU OREME (SO ECOPOP) no grant number
6 · The paper itself

Abstract

Despite the fact that the selective pressure of antibiotics on wild birds is supposed to be very weak, they are considered potential vectors of antimicrobial resistance (AMR). Obligate scavengers such as vultures can present high proportions of resistance to extended-spectrum cephalosporins (ESC) and multi-drug-resistant (MDR) bacteria, partially due to feeding stations that are provisioned with livestock carcasses from intensive farming. Here we investigated whether griffon vultures (

Indexed as

ESBLGyps fulvusmulti-drug resistancescavengingwild birds

Identifiers

PMID37508256
PMCPMC10376662
OpenAlexW4383723927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.